Binding of [¹²⁵I]Bolton Hunter conjugated eledoisin to rat brain cortex membranes. Evidence for two classes of tachykinin receptors in the mammalian central nervous systemCASCIERI, M. A; TEHMING LIANG.Life sciences (1973). 1984, Vol 35, Num 2, pp 179-184, issn 0024-3205Article

Two-dimensional electrophoretic analysis of secretory-granule, granule-membrane, and plasma-membrane proteins of rat parotid cellsCASCIERI, M. A; SOMBERG, E. W.Cell and tissue research. 1983, Vol 234, Num 1, pp 93-108, issn 0302-766XArticle

Demonstration of two distinct tachykinin receptors in rat brain cortexCASCIERI, M. A; CHICCHI, G. G; TEHMING LIANG et al.The Journal of biological chemistry (Print). 1985, Vol 260, Num 3, pp 1501-1507, issn 0021-9258Article

Characterization of the increased biological potency in BALB/C 3T3 cells of two analogs of human insulinlike growth factor I which have reduced affinity for the 28 k cell-derived binding proteinCASCIERI, M. A; HAYES, N. S; BAYNE, M. L et al.Journal of cellular physiology. 1989, Vol 139, Num 1, pp 181-188, issn 0021-9541, 8 p.Article

Structural determinants for the binary and ternary complex formation between insulin-like growth factor-I (IGF-I) and IGF binding protein-3BAXTER, R. C; BAYNE, M. L; CASCIERI, M. A et al.The Journal of biological chemistry (Print). 1992, Vol 267, Num 1, pp 60-65, issn 0021-9258Article

Synthesis and SAR of benzyl and phenoxymethylene oxadiazole benzenesulfonamides as selective β₃ adrenergic receptor agonist antiobesity agentsBIFTU, T; FENG, D. D; FORREST, M. J et al.Bioorganic & medicinal chemistry letters (Print). 2000, Vol 10, Num 13, pp 1431-1434, issn 0960-894XArticle

Human β₃ adrenergic receptor agonists containing imidazolidinone and imidazolone benzenesulfonamidesNAYLOR, E. M; PARMEE, E. R; FORREST, M. J et al.Bioorganic & medicinal chemistry letters (Print). 1999, Vol 9, Num 5, pp 755-758, issn 0960-894XArticle

3-Benzyloxy-2-phenylpiperidine NK₁ antagonists : The influence of alpha methyl substitutionSWAIN, C. J; WILLIAMS, B. J; MACINTYRE, D. E et al.Bioorganic & medicinal chemistry letters (Print). 1997, Vol 7, Num 23, pp 2959-2962, issn 0960-894XArticle

Synthesis and biological evaluation of NK₁ antagonists derived from L-tryptophanMACLEOD, A. M; CASCIERI, M. A; TATTERSALL, F. D et al.Journal of medicinal chemistry (Print). 1995, Vol 38, Num 6, pp 934-941, issn 0022-2623Article

Tryptophan-derived NK₁ antagonists : conformationally constrained heterocyclic bioisosteres of the ester linkageLEWIS, R. T; MACLEOD, A. M; MERCHANT, K. J et al.Journal of medicinal chemistry (Print). 1995, Vol 38, Num 6, pp 923-933, issn 0022-2623Article

Identification of a series of 3-(benzyloxy)-1-azabicyclo[2.2.2]octane human NK₁, antagonistsSWAIN, C. J; SEWARD, E. M; TEALL, M et al.Journal of medicinal chemistry (Print). 1995, Vol 38, Num 24, pp 4793-4805, issn 0022-2623Article

Characterization of the interaction of N-acyl-L-tryptophan benzyl ester neurokinin antagonists with the human neurokinin-1 receptorCASCIERI, M. A; MACLEOD, A. M; TUNG MING FONG et al.The Journal of biological chemistry (Print). 1994, Vol 269, Num 9, pp 6587-6591, issn 0021-9258Article

The role of histidine 265 in antagonist binding to the neurokinin-1 receptorTUNG MING FONG; HONG YU; CASCIERI, M. A et al.The Journal of biological chemistry (Print). 1994, Vol 269, Num 4, pp 2728-2732, issn 0021-9258Article

Discovery of an orally bioavailable alkyl oxadiazole β₃ adrenergic receptor agonistFENG, D. D; BIFTU, T; MILLER, R. R et al.Bioorganic & medicinal chemistry letters (Print). 2000, Vol 10, Num 13, pp 1427-1429, issn 0960-894XArticle

3-Pyridyloxypropanolamine agonists of the β₃ adrenergic receptor with improved pharmacokinetic propertiesWEBER, A. E; OK, H. O; KAO, J et al.Bioorganic & medicinal chemistry letters (Print). 1998, Vol 8, Num 16, pp 2111-2116, issn 0960-894XArticle

Serine derived NK₁ antagonists 1 : The effect of modifications to the serine substituentsELLIOTT, J. M; CASCIERI, M. A; SADOWSKI, S et al.Bioorganic & medicinal chemistry letters (Print). 1998, Vol 8, Num 14, pp 1845-1850, issn 0960-894XArticle

Characterization of the binding and activity of a high affinity, pseudoirreversible morpholino tachykinin NK₁ receptor antagonistCASCIERI, M. A; BER, E; STRADER, C. D et al.European journal of pharmacology. 1997, Vol 325, Num 2-3, pp 253-261, issn 0014-2999Article

In vitro and in vivo predictors of the anti-emetic activity of tachykinin NK₁ receptor antagonistsRUPNIAK, N. M. J; TATTERSALL, F. D; MACCOSS, M et al.European journal of pharmacology. 1997, Vol 326, Num 2-3, pp 201-209, issn 0014-2999Article

L-733,060, a novel tachykinin NK₁ receptor antagonist ; effects in [Ca²⁺]_i mobilisation, cardiovascular and dural extravasation assaysSEABROOK, G. R; SHEPHEARD, S. L; WILLIAMSON, D. J et al.European journal of pharmacology. 1996, Vol 317, Num 1, pp 129-135, issn 0014-2999Article

1,4-diacylpiperazine-2-(S)-[(N-aminoalkyl)carboxamides] as novel, potent substance P receptor antagonistsMILLS, S. G; MU TSU WU; MACCOSS, M et al.Bioorganic & medicinal chemistry letters (Print). 1993, Vol 3, Num 12, pp 2707-2712, issn 0960-894XArticle

Effect of charybdotoxin and leiurotoxin I on potassium currents in bullfrog sympathetic ganglion and hippocampal neuronsGOH, J. W; KELLY, M. E. M; PENNEFATHER, P. S et al.Brain research. 1992, Vol 591, Num 1, pp 165-170, issn 0006-8993Article

Endogenous insulin-like growth factor (IGF) binding proteins cause IGF-I resistance in cultured fibroblasts from a patient with short statureTOLLEFSEN, S. E; HEATH-MONNIG, E; CASCIERI, M. A et al.The Journal of clinical investigation. 1991, Vol 87, Num 4, pp 1241-1250, issn 0021-9738Article

Azasteroids: structure-activity relationships for inhibition of 5α-reductase and of androgen receptor bindingRASMUSSON, G. H; REYNOLDS, G. F; STEINBERG, N. G et al.Journal of medicinal chemistry (Print). 1986, Vol 29, Num 11, pp 2298-2315, issn 0022-2623Article

L-770,644 : A potent and selective human β₃ adrenergic receptor agonist with improved oral bioavailabilitySHIH, T. L; CANDELORE, M. R; MILLER, R. R et al.Bioorganic & medicinal chemistry letters (Print). 1999, Vol 9, Num 9, pp 1251-1254, issn 0960-894XArticle

Potent, selective human β₃ adrenergic receptor agonists containing A substituted indoline-5-sulfonamide pharmacophoreMATHVINK, R. J; BARRITTA, A. M; CANDELORE, M. R et al.Bioorganic & medicinal chemistry letters (Print). 1999, Vol 9, Num 13, pp 1869-1874, issn 0960-894XArticle